B of A Securities Initiates Coverage On CG Oncology with Buy Rating, Announces Price Target of $65
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has initiated coverage on CG Oncology (NASDAQ:CGON) with a Buy rating and a price target of $65, as announced by analyst Charlie Yang.
June 28, 2024 | 10:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B of A Securities has initiated coverage on CG Oncology with a Buy rating and a price target of $65, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $65 by a reputable firm like B of A Securities is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100